Recruiting NCT04933370
Neuromodulation Parameter Efficacy
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Stimulation parameters.
- Who it may be relevant to
- Registry conditions: Chronic Pain. Basic parameters: 18 years — 100 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Canada
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Evaluating the Efficacy of Different Stimulation Paradigms in Neuromodulation
Overview
The objective of this study is to determine the efficacy of neuromodulation using various stimulation paradigms in the treatment of several disorders including chronic pain.
Detailed description
Different stimulation parameters will be tried in a blinded fashion to compare efficacy.
Interventions
- Other Stimulation parameters
Different device stimulation parameters
Primary outcome measures
- Change in baseline pain measures [Time frame: 6 months]
Secondary outcome measures (1)
- Effect of stimulation on quality of life [Time frame: 6 months]
Eligibility criteria
Inclusion criteria
- Patients who are candidates for, and have been consented for, implantation of a neuromodulation device.
Exclusion criteria
- Non-English speaking
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Quadruple blind
- Primary purpose
- Treatment
Study locations
Canada · 1 center
- University of Calgary — Calgary
Identifiers
NCT: NCT04933370 · REB21-0692